Systemic Lupus Erythematosus

Anti-DNA antibodies

Introduction Elevated anti-double-stranded (ds) DNA antibody titers are diagnostic and prognostic markers of systemic lupus erythematosus (SLE), and their presence is well documented to correlate with lupus nephritis. These antibodies are often deposited in the glomeruli and can be eluted…

Origin of autoantibodies

Production of antinuclear antibodies (ANA) is a consistent manifestation of SLE (frequency ∼100%) and often the earliest. This is not due to a global loss of tolerance, as the antigenic targets are highly restricted. Indeed, autoantibodies against chromatin/DNA, U1 small…

Infections in early systemic lupus erythematosus pathogenesis

Introduction Patients with systemic lupus erythematosus (SLE) may experience arthritis, serositis, renal involvement, and a wide range of other clinical manifestations with the potential to affect nearly any organ system. These pathologies are driven by chronic inflammation and the presence…

Apoptosis, autophagy, and necrosis

Two and a half millennia ago Hippocrates used the word “apoptosis” to describe the gangrene resulting from treatment of fractures with bandages. Interestingly, he was describing a pathological form of tissue (cell) death. In 1972 Kerr reused the word “apoptosis”…

Fcγ receptors in autoimmunity and end-organ damage

Introduction Antibodies are potent inducers of inflammation. A consistent feature of systemic lupus erythematosus (SLE) is the presence of autoantibodies and complement-fixing immune complexes (ICs) resulting in inflammatory lesions in multiple organ systems. Fc receptors, the receptors for IgG antibodies,…

RNA/DNA sensing in SLE—Toll-like receptors and beyond

Introduction In recent years it has become increasingly clear that aberrant response to nucleic acids (be they endogenous or exogenous) in systemic lupus erythematosus (SLE) patients plays a large role in triggering and sustaining the disruption of immune responses in…

Cytokines

Cytokines in SLE Cytokines produced by the cells of the innate immune system important in SLE pathogenesis include interferon alpha (IFN-α), interleukin (IL)-1, IL-6, tumor necrosis factor (TNF), IL-10, B cell activating factor (BAFF), and a proliferation inducing ligand (APRIL).…